Cetera Investment Advisers Humacyte, Inc. Transaction History
Cetera Investment Advisers
- $44.2 Billion
- Q3 2024
A detailed history of Cetera Investment Advisers transactions in Humacyte, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 18,746 shares of HUMA stock, worth $86,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,746
Previous 15,711
19.32%
Holding current value
$86,419
Previous $75,000
34.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HUMA
# of Institutions
149Shares Held
35.1MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$32.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$23.3 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$22 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$9.41 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.84 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $475M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...